LinkDoc Technology
Founded Year
2014Stage
Corporate Minority | AliveTotal Raised
$253.02MMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-54 points in the past 30 days
About LinkDoc Technology
LinkDoc Technology provides healthcare big data and AI solutions in oncology and precision medicine. The services include structuring clinical electronic medical records into research-grade data, offering real-world evidence services, and creating platforms for clinical decision support and digital therapeutics. The company serves the healthcare industry, including hospitals, pharmaceutical companies, and insurance institutions. It was founded in 2014 and is based in Beijing, Beijing.
Loading...
LinkDoc Technology's Product Videos
LinkDoc Technology's Products & Differentiators
Data Curation
We are devoted to advancing state-of-the-art medical data technology, processes and analytics to unlock the critical data bottleneck in healthcare by generating high-quality data with transformative efficiency, quality and accuracy. We have developed industry-leading and differentiated technologies and have built the largest oncology patient cohorts in China capable of integrating clinical, genomic and outcome data on the individual level to systematize raw patient data at a new level of efficiency and accuracy.
Loading...
Expert Collections containing LinkDoc Technology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
LinkDoc Technology is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Digital Health 50
150 items
The most promising digital health startups transforming the healthcare industry
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
571 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Artificial Intelligence (AI)
9,236 items
Latest LinkDoc Technology News
Aug 14, 2025
닫기 [팜뉴스=김응민 기자] 국가임상시험지원재단(이사장 박인석, 이하 '재단')은 오는 9월 22일부터 24일까지 서울 소공동 롯데호텔에서 열리는 '2025 KoNECT-MOHW-MFDS 국제콘퍼런스(KIC)'의 세션 중 하나로, 9월 22일 오전 10시부터 2층 크리스탈볼룸에서 '신약개발에서의 인공지능(AI) 활용 가능성과 과제'를 주제로 토크쇼를 개최한다고 13일 밝혔다. 이번 세션은 AI 기술이 신약개발 패러다임에 미치는 변화와 이를 둘러싼 과학적·기술적, 정책적 이슈를 심도 있게 다루기 위해 기획됐다. 좌장은 정재호 연세대학교 양자사업단장(융합과학기술원장)이 맡으며, 기조 발표는 KAIST 최정균 교수가 진행한다. 최 교수는 유전체 기반 신약개발과 AI 융합 연구를 이끌어 온 전문가로, AI가 저분자 화합물 의약품 개발을 넘어 바이오의약품 개발로 영역을 확장시키는 과정과 그 과학적 의미를 제시할 예정이다. 이어지는 패널 토의에서는 AI의 신약개발 전주기 적용 사례와 성과, 데이터 신뢰성 확보와 규제기관 수용 방안, AI 적용 과정에서의 한계와 개선 전략 등에 대해 국내외 전문가들이 실제 사례를 중심으로 토론한다. 이번 토크쇼에는 임상시험, AI 기술, 정책, 학계 등 다양한 분야의 전문가들이 참여한다. 중국 병원 데이터를 기반으로 폐암 진단·치료 AI 프로젝트를 수행한 링크닥(LinkDoc)의 토니 장 대표는 의료 현장에서의 AI 적용 경험을, 메디데이터(Medidata)에서 AI 전략개발을 이끄는 지아 첸 전무는 예측 모델과 합성 대조군 등 기술을 통한 임상시험 가속화 방안을 공유한다. 또한 미국 의료인공지능연합(AAIH) 공동창립자이자 전 리커전 캐나다·사이클리카 대표인 나히드 커지는 글로벌 제약·기술 기업 간 협업 및 정책 연계 전략을 제시하며, 한미약품 전해민 상무는 국내 제약사의 AI 도입 현황과 개발 효율성 개선 사례를, LG AI연구원 박용민 팀장은 생성형 AI 기반 신약 설계와 임상시험 최적화 플랫폼, 글로벌 파트너십 모델을 소개한다. 정부 부문에서는 미국 매사추세츠주 최고디지털책임자 자낙 조시가 공공 부문의 디지털 헬스 전략과 데이터 기반 임상 혁신 가능성을 발표하고, 학계에서는 최정균 교수 외에 서울대학교 석차옥 교수가 AI 활용 분자 구조 예측과 약물-타깃 상호작용 모델링 연구 성과를, 영국 케임브리지대학교 한남식 박사가 AI 기반 약물 재창출과 디지털 바이오마커 개발 등 유럽 현장 사례를 통해 신뢰할 수 있는 AI 활용 조건을 설명할 예정이다. 박인석 재단 이사장은 "인공지능은 더 이상 미래 기술이 아니라 임상시험과 신약개발의 현재를 변화시키는 핵심 동력"이라며 "이번 KIC가 업계·학계·규제기관이 함께 새로운 표준과 협력 모델을 만드는 계기가 되길 기대한다"고 말했다. 2025 KIC 사전등록은 오는 8월 22일까지 공식 홈페이지를 통해 온라인으로 가능하다.
LinkDoc Technology Frequently Asked Questions (FAQ)
When was LinkDoc Technology founded?
LinkDoc Technology was founded in 2014.
Where is LinkDoc Technology's headquarters?
LinkDoc Technology's headquarters is located at 11/F, China Steel International Plaza, Beijing.
What is LinkDoc Technology's latest funding round?
LinkDoc Technology's latest funding round is Corporate Minority.
How much did LinkDoc Technology raise?
LinkDoc Technology raised a total of $253.02M.
Who are the investors of LinkDoc Technology?
Investors of LinkDoc Technology include Alibaba Health, China Broadband Capital, China Capital Investment Group, Youshan Capital, China Investment Corporation and 7 more.
Who are LinkDoc Technology's competitors?
Competitors of LinkDoc Technology include ABC Clinic Manager and 7 more.
What products does LinkDoc Technology offer?
LinkDoc Technology's products include Data Curation and 2 more.
Loading...
Compare LinkDoc Technology to Competitors
FIRE1 focuses on solutions for managing heart failure within the medical device industry. The company offers a home monitoring medical device that enables patients to track their heart status daily and share this information with their healthcare providers. It was founded in 2013 and is based in Dublin 11, Ireland.
Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.
BaseBit operates as a company focused on the operation and enablement of the internet of data and computing within the data and computing industry. The company's main services involve leveraging privacy computing technologies to facilitate authorized data sharing, create data liquidity, lower the barriers of data science for all, and advance artificial intelligence. It was founded in 2015 and is based in Shanghai, Shanghai.
OrSense is a medical device company specializing in non-invasive monitoring systems within the healthcare industry. The company offers devices that measure hemoglobin, oxygen saturation, and pulse rate using a proprietary occlusion spectroscopy technology. OrSense primarily serves the medical monitoring sector, with products designed for blood donation facilities and other healthcare applications. It is based in Israel.
FloShield specializes in enhancing laparoscopic surgery vision through its medical device technology. The company offers a system that maintains clear vision for surgeons by preventing the laparoscope lens from getting dirty, using a method known as Vortex Barrier Technology, and provides an option for intraoperative lens cleaning with Flo-X in situ. It was founded in 2009 and is based in Cupertino, California.
Endothelix provides a product, the VENDYS II, which is an automated device designed for the medical sector. The device offers a noninvasive assessment of cardiovascular event risk levels, catering to healthcare providers. VENDYS II is FDA-cleared for measuring vascular reactivity and endothelial function in an office-based setting. It was founded in 2003 and is based in Houston, Texas.
Loading...